Conversely, platelet-derived growth factor-D (PDGF-D) is primarily derived from the tumor cells, which activates RAC1/CDC42 and JNK pathways within CAFs, thereby stimulating their activation and migratory capacity (38). This evidence concerns the gene PDGFD and neoplasm.